Skip to content
GT Medical Technologies
Menu
  • GammaTile Therapy
    • Elevating Outcomes
    • Advancing Safety
    • How It Works
  • Clinical Resources
    • Roads
    • Gestalt
  • GammaTile Centers
  • Recruiting Trials
  • Tumor Bed Calculator
  • News
  • Events
  • Contact

Topic: Clinical Publications and Awards

GammaTile in Brain Tumor Treatment: Technical & Clinical Overview by Dr. Michael A. Garcia, Dr. Adam Turner and Dr. David G. Brachman

GammaTile® (GT) as a brachytherapy platform forrapidly growing brain metastasis

Surgically Targeted Radiation Therapy (STaRT) for brain metastases:Initial Experience from a Prospective Multi-institutional Registry (NCT04427384)

CS-131 for Operable Intracranial Neoplasms

Dr. Kotecha: Radiation therapy can be delivered to the brain externally through machines, which is called external beam radiation therapy. This is the most common approach or use in radiation therapy and some terms that you may hear that are using this type of treatment are stereotactic radiosurgery. An alternative means of delivering radiation therapy is when radiation is actually implanted into the brain itself, and that is called brachytherapy.

GammaTile® Brachytherapy in the Treatment of Recurrent Glioblastomas

Neuro-Oncology Advances 2021 | Dominic J Gessler, Elizabeth C Neil, Rena Shah, Joseph Levine, James Shanks, Christopher Wilke, Margaret Reynolds, Shunqing Zhang, Can Özütemiz, Mehmet Gencturk, Mark Folkertsma, W Robert Bell, Liam Chen, Clara Ferreira, Kathryn Dusenbery, Clark C Chen. GammaTile® Brachytherapy in the Treatment of Recurrent Glioblastomas [published online December 27, 2021]. https://doi.org/10.1093/noajnl/vdab185

Safety and Efficacy of GammaTile Intracranial Brachytherapy Implanted During Awake Craniotomy

Brachytherapy 2021 | Shearwood McClelland, Ulysses G Gardner, Yi Le, Sook Kien Ng, Mitesh V Shah, Gordon A Watson. Safety and efficacy of GammaTile intracranial brachytherapy implanted during awake craniotomy [published online September 26, 2021]. Brachytherapy. doi.org/10.1016/j.brachy.2021.08.011.

First Clinical Implementation of GammaTile Permanent Brain Implants After FDA Clearance

Brachytherapy 2021 | Ferreira C, Sterling C, Reynolds M, Dusenbery K, Chen C, Alaei A. First clinical implementation of GammaTile permanent brain implants after FDA clearance [published online ahead of print January 21,2021]. Brachytherapy. doi: 10.1016/j.brachy.2020.12.005.

Emory University School of Medicine

Surgical Outcomes of a Novel Collagen Tile Cesium Brachytherapy for Intracranial Malignancy at a Tertiary Referral Center

2020 Georgia Neurosurgical Society Annual Fall Meeting | Andrew B. Boucher, MD; Hui-Kuo Shu MD, PhD; Jeffrey J. Olson, MD; Kimberly B. Hoang, MD. Emory University. Presented at 2020 Georgia Neurosurgical Society Annual Fall Meeting.

A Prospective Trial of Resection and Surgically Targeted Radiation Therapy for Initial or Salvage Treatment of Aggressive Meningioma

SNO Annual Meeting 2020 | L. Rogers, P. Nakaji, E. Youssef, K. Smith, J. Zabramski, T. Thomas, C. Dardis, D. Pinnaduwage and D. Brachman; St Joseph’s Hospital, Phoenix, AZ, Barrow Neurological Institute, Phoenix, AZ, GT Medical Technologies, Tempe, AZ.

Cureus

Resection and Surgically Targeted Radiation Therapy for the Treatment of Larger Recurrent or Newly Diagnosed Brain Metastasis: Results From a Prospective Trial

Cureus 2020 | Peter Nakaji, Kris Smith, Emad Youssef, Theresa Thomas, Dilini Pinnaduwage, Leland Rogers, Garrick Wallstrom, David Brachman. Cureus. 2020;12(11):e11570.

Posts navigation

Older posts

IMPROVING THE LIVES OF PATIENTS WITH BRAIN TUMORS

  • GammaTile Therapy
  • Clinical Resources
  • GammaTile Centers
  • News
  • Events
  • About Us
  • Contact
  • Ordering
  • Returns

©2025 GT Medical Technologies, Inc. | All rights reserved | Instructions for Use | Privacy Policy | Terms of Use

We use cookies to enhance your browsing experience and analyze our traffic. By clicking "Accept", you consent to our use of cookies.AcceptPrivacy policy